Picture-to-puncture time in acute stroke endovascular intervention: are we getting faster?

vascular

J NeuroIntervent Surg: 6/26/14 Abstract Background In acute stroke management, time efficiency in the continuum of patient management is critical. We aimed to determine if implementation of system improvements at our institution translated to reduced picture-to-puncture (P2P) times over a 6-year period. Methods We conducted a single-center retrospective analysis using a prospective acute stroke database of patients treated […]

Validity of Claims-Based Stroke Algorithms in Contemporary Medicare Data

Ischemic Stroke

CIRCOUTCOMES: June 24, 2014 Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Linked With Medicare Claims Background—The accuracy of stroke diagnosis in administrative claims for a contemporary population of Medicare enrollees has not been studied. We assessed the validity of diagnostic coding algorithms for identifying stroke in the Medicare population by linking data from […]

Outdoor air pollution, subtypes and severity of ischemic stroke – a small-area level ecological study

smoker

International Journal of Health Geographics: 6/17/14 Background Evidence linking outdoor air pollution and incidence of ischemic stroke subtypes and severity is limited. We examined associations between outdoor PM10 and NO2 concentrations modeled at a fine spatial resolution and etiological and clinical ischemic stroke subtypes and severity of ischemic stroke. Methods We used a small-area level ecological study design […]

Impact of living and socioeconomic characteristics on cardiovascular risk in ischemic stroke patients

Wiley: 12 JUN 2014 Conflict of interest: Dr. Amarenco has received research funding from Pfizer, AstraZeneca, Merck, Sanofi-Aventis, and BMS; speaker fees from Pfizer, Sanofi-Aventis, Bayer, Boehringer-Ingelheim, AstraZeneca, and Otsuka Pharmaceutical; and honoraria from Pfizer, Sanofi-Aventis, Bristol-Myers Squibb, Merck, Kowa, Lundbeck, Boston Scientific, Edwards, Bayer, and Boehringer-Ingelheim. Dr. Abboud has no conflicts of interest to […]

Management of acute stroke in patients taking novel oral anticoagulants

Wiley: 2 JUN 2014 Funding: Professor Thorsten Steiner has received honoraria from Boehringer, Bayer, and BMS–Pfizer. Professor Bo Norrving has acted as consultant for Bayer HealthCare, Servier, Syngis, Daichii Sankyo and Allergan, and has received royalties for a book published by Karolinska University Press. Professor Graeme Hankey has received honoraria for serving on the executive committees […]

Race/Ethnic Differences in the Risk of Hemorrhagic Complications Among Patients With Ischemic Stroke Receiving Thrombolytic Therapy

STROKEAHA: June 24, 2014 Background and Purpose—Race/ethnic-related differences in safety of intravenous thrombolytic therapy have been shown in patients with myocardial infarction, but not studied in ischemic stroke. Methods—Using data from the Get With The Guidelines (GWTG)-Stroke program (n=54 334), we evaluated differences in risk-adjusted bleeding rates (any, symptomatic intracerebral hemorrhage [sICH], serious life-threatening [excluding sICH], […]

Stroke Prevention in Women: Synopsis of the 2014 American Heart Association/American Stroke Association Guideline

Annals – Clinical Guidelines | 17 June 2014 Description: In February 2014, the American Heart Association/American Stroke Association released their first guideline focused on stroke prevention in women. This new guideline highlights unique risk factors for stroke in women, including oral contraception and hormone therapy, and pregnancy-associated disorders, such as preeclampsia, that may have long-lasting consequences on a woman’s health. It […]

Atrial Fibrillation, Stroke, and Anticoagulation in Medicare Beneficiaries: Trends by Age, Sex, and Race, 1992–2010

J Am Heart Assoc: June 3, 2014 Background We evaluated temporal trends in ischemic stroke and warfarin use among demographic subsets of the US Medicare population that are not well represented in randomized trials of warfarin for stroke prevention in nonvalvular atrial fibrillation (AF). Methods and Results One‐year cohorts of Medicare–primary payer patients (1992–2010) were created using the […]

Decision Making in Acute Stroke Care

STROKEAHA: May 29, 2014 Making decisions in medical care is a difficult task, involving a variety of cognitive processes. Decision making is defined as the process of examining possibilities, risks, uncertainties, and options, comparing them, and choosing a course of action.1,2 Decisions based on erroneous assessments may result in incorrect patient and family expectations, and potentially […]

Hospital-Directed Feedback to Emergency Medical Services Improves Prehospital PerformanceSTROKEAHA

STROKEAHA.: May 29, 2014 Background and Purpose—A potential way to improve prehospital stroke care and patient handoff is hospital-directed feedback for emergency medical service (EMS) providers. We evaluated whether a hospital-directed EMS stroke follow-up tool improved documentation of adherence to the Rhode Island state prehospital stroke protocol for EMS providers. Methods—A standardized, 10-item feedback tool […]

Sign Up Now
National Minority Quality Forum
Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2012 National Minority Quality Forum, Inc. All Rights Reserved.